CHARTWELL INVESTMENT PARTNERS, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2020$957,000
-0.5%
16,362
+36.3%
0.04%
+40.6%
Q4 2019$962,000
-44.9%
12,004
-49.5%
0.03%
-44.8%
Q3 2019$1,747,000
-22.1%
23,7750.0%0.06%
-20.5%
Q2 2019$2,243,000
+43.3%
23,775
+21.6%
0.07%
+43.1%
Q1 2019$1,565,00019,5560.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders